Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: The Mayo Clinic proteomic markers of arteriosclerosis study

Charles X. Kim, Kent R Bailey, George G. Klee, Allison A. Ellington, Guanghui Liu, Thomas H. Mosley, Hamid Rehman, Iftikhar Jan Kullo

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Background: Cardiovascular disease (CVD) susceptibility differs between men and women and varies with ethnicity. This variability is not entirely explained by conventional CVD risk factors. We examined differences in circulating levels of 47 novel protein markers of CVD in 2561 men and women of African-American (AA) and non-Hispanic White (NHW) ethnicity, enrolled at geographically distinct sites. Methodology/Principal Findings: Participants (1,324 AAs, mean age 63.5 y, 71% women; 1,237 NHWs, mean age 58.9 y, 57% women) belonged to sibships ascertained on the basis of hypertension. Solid-phase immunoassays and immunoturbidometric, clot-based, chromogenic, and electrophoretic assays were used to measure the 47 protein markers in plasma or serum. Marker levels were log transformed and outliers were adjusted to within 4 SD. To identify markers independently associated with sex or ethnicity, we employed multivariable regression analyses that adjusted for conventional risk factors, prior history of CVD, medication use and lifestyle factors (physical activity, alcohol consumption and education). Generalized estimating equations were used to correct for intrafamilial correlations. After adjustment for the above covariates, female sex was associated with higher levels of 29 markers and lower levels of 6 markers. Female sex was independently associated with higher levels of several inflammatory markers as well as lipoproteins, adipokines, natriuretic peptides, vasoconstrictor peptides and markers of calcification and thrombosis. AA ethnicity was associated with higher levels of 19 markers and lower levels of 6 markers, including higher levels of several inflammatory makers, higher leptin and lower adiponectin levels, lower levels of vasodilator-natriuretic peptides, higher levels of vasoconstrictor-antidiuretic peptides and markers of calcification and thrombosis. Conclusions/Significance: Plasma levels of several novel protein markers of CVD differ significantly in the context of sex and ethnicity. These results have implications for individualized CVD risk assessment.

Original languageEnglish (US)
Article numbere9065
JournalPLoS One
Volume5
Issue number2
DOIs
StatePublished - Feb 5 2010

Fingerprint

ethnic differences
Arteriosclerosis
gender differences
Sex Characteristics
Proteomics
proteomics
cardiovascular diseases
nationalities and ethnic groups
Cardiovascular Diseases
natriuretic peptides
vasoconstrictor agents
Natriuretic Peptides
gender
thrombosis
calcification
Vasoconstrictor Agents
African Americans
Thrombosis
risk factors
peptides

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease : The Mayo Clinic proteomic markers of arteriosclerosis study. / Kim, Charles X.; Bailey, Kent R; Klee, George G.; Ellington, Allison A.; Liu, Guanghui; Mosley, Thomas H.; Rehman, Hamid; Kullo, Iftikhar Jan.

In: PLoS One, Vol. 5, No. 2, e9065, 05.02.2010.

Research output: Contribution to journalArticle

Kim, Charles X. ; Bailey, Kent R ; Klee, George G. ; Ellington, Allison A. ; Liu, Guanghui ; Mosley, Thomas H. ; Rehman, Hamid ; Kullo, Iftikhar Jan. / Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease : The Mayo Clinic proteomic markers of arteriosclerosis study. In: PLoS One. 2010 ; Vol. 5, No. 2.
@article{2051550544a648eeb3ddf08ff3d995dd,
title = "Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: The Mayo Clinic proteomic markers of arteriosclerosis study",
abstract = "Background: Cardiovascular disease (CVD) susceptibility differs between men and women and varies with ethnicity. This variability is not entirely explained by conventional CVD risk factors. We examined differences in circulating levels of 47 novel protein markers of CVD in 2561 men and women of African-American (AA) and non-Hispanic White (NHW) ethnicity, enrolled at geographically distinct sites. Methodology/Principal Findings: Participants (1,324 AAs, mean age 63.5 y, 71{\%} women; 1,237 NHWs, mean age 58.9 y, 57{\%} women) belonged to sibships ascertained on the basis of hypertension. Solid-phase immunoassays and immunoturbidometric, clot-based, chromogenic, and electrophoretic assays were used to measure the 47 protein markers in plasma or serum. Marker levels were log transformed and outliers were adjusted to within 4 SD. To identify markers independently associated with sex or ethnicity, we employed multivariable regression analyses that adjusted for conventional risk factors, prior history of CVD, medication use and lifestyle factors (physical activity, alcohol consumption and education). Generalized estimating equations were used to correct for intrafamilial correlations. After adjustment for the above covariates, female sex was associated with higher levels of 29 markers and lower levels of 6 markers. Female sex was independently associated with higher levels of several inflammatory markers as well as lipoproteins, adipokines, natriuretic peptides, vasoconstrictor peptides and markers of calcification and thrombosis. AA ethnicity was associated with higher levels of 19 markers and lower levels of 6 markers, including higher levels of several inflammatory makers, higher leptin and lower adiponectin levels, lower levels of vasodilator-natriuretic peptides, higher levels of vasoconstrictor-antidiuretic peptides and markers of calcification and thrombosis. Conclusions/Significance: Plasma levels of several novel protein markers of CVD differ significantly in the context of sex and ethnicity. These results have implications for individualized CVD risk assessment.",
author = "Kim, {Charles X.} and Bailey, {Kent R} and Klee, {George G.} and Ellington, {Allison A.} and Guanghui Liu and Mosley, {Thomas H.} and Hamid Rehman and Kullo, {Iftikhar Jan}",
year = "2010",
month = "2",
day = "5",
doi = "10.1371/journal.pone.0009065",
language = "English (US)",
volume = "5",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "2",

}

TY - JOUR

T1 - Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease

T2 - The Mayo Clinic proteomic markers of arteriosclerosis study

AU - Kim, Charles X.

AU - Bailey, Kent R

AU - Klee, George G.

AU - Ellington, Allison A.

AU - Liu, Guanghui

AU - Mosley, Thomas H.

AU - Rehman, Hamid

AU - Kullo, Iftikhar Jan

PY - 2010/2/5

Y1 - 2010/2/5

N2 - Background: Cardiovascular disease (CVD) susceptibility differs between men and women and varies with ethnicity. This variability is not entirely explained by conventional CVD risk factors. We examined differences in circulating levels of 47 novel protein markers of CVD in 2561 men and women of African-American (AA) and non-Hispanic White (NHW) ethnicity, enrolled at geographically distinct sites. Methodology/Principal Findings: Participants (1,324 AAs, mean age 63.5 y, 71% women; 1,237 NHWs, mean age 58.9 y, 57% women) belonged to sibships ascertained on the basis of hypertension. Solid-phase immunoassays and immunoturbidometric, clot-based, chromogenic, and electrophoretic assays were used to measure the 47 protein markers in plasma or serum. Marker levels were log transformed and outliers were adjusted to within 4 SD. To identify markers independently associated with sex or ethnicity, we employed multivariable regression analyses that adjusted for conventional risk factors, prior history of CVD, medication use and lifestyle factors (physical activity, alcohol consumption and education). Generalized estimating equations were used to correct for intrafamilial correlations. After adjustment for the above covariates, female sex was associated with higher levels of 29 markers and lower levels of 6 markers. Female sex was independently associated with higher levels of several inflammatory markers as well as lipoproteins, adipokines, natriuretic peptides, vasoconstrictor peptides and markers of calcification and thrombosis. AA ethnicity was associated with higher levels of 19 markers and lower levels of 6 markers, including higher levels of several inflammatory makers, higher leptin and lower adiponectin levels, lower levels of vasodilator-natriuretic peptides, higher levels of vasoconstrictor-antidiuretic peptides and markers of calcification and thrombosis. Conclusions/Significance: Plasma levels of several novel protein markers of CVD differ significantly in the context of sex and ethnicity. These results have implications for individualized CVD risk assessment.

AB - Background: Cardiovascular disease (CVD) susceptibility differs between men and women and varies with ethnicity. This variability is not entirely explained by conventional CVD risk factors. We examined differences in circulating levels of 47 novel protein markers of CVD in 2561 men and women of African-American (AA) and non-Hispanic White (NHW) ethnicity, enrolled at geographically distinct sites. Methodology/Principal Findings: Participants (1,324 AAs, mean age 63.5 y, 71% women; 1,237 NHWs, mean age 58.9 y, 57% women) belonged to sibships ascertained on the basis of hypertension. Solid-phase immunoassays and immunoturbidometric, clot-based, chromogenic, and electrophoretic assays were used to measure the 47 protein markers in plasma or serum. Marker levels were log transformed and outliers were adjusted to within 4 SD. To identify markers independently associated with sex or ethnicity, we employed multivariable regression analyses that adjusted for conventional risk factors, prior history of CVD, medication use and lifestyle factors (physical activity, alcohol consumption and education). Generalized estimating equations were used to correct for intrafamilial correlations. After adjustment for the above covariates, female sex was associated with higher levels of 29 markers and lower levels of 6 markers. Female sex was independently associated with higher levels of several inflammatory markers as well as lipoproteins, adipokines, natriuretic peptides, vasoconstrictor peptides and markers of calcification and thrombosis. AA ethnicity was associated with higher levels of 19 markers and lower levels of 6 markers, including higher levels of several inflammatory makers, higher leptin and lower adiponectin levels, lower levels of vasodilator-natriuretic peptides, higher levels of vasoconstrictor-antidiuretic peptides and markers of calcification and thrombosis. Conclusions/Significance: Plasma levels of several novel protein markers of CVD differ significantly in the context of sex and ethnicity. These results have implications for individualized CVD risk assessment.

UR - http://www.scopus.com/inward/record.url?scp=77949393795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949393795&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0009065

DO - 10.1371/journal.pone.0009065

M3 - Article

C2 - 20140090

AN - SCOPUS:77949393795

VL - 5

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 2

M1 - e9065

ER -